Skip to content
Clinical ResearchResearch compound

Topilutamide

Scalp product against hair loss (fluridil) sold as a cosmetic; in humans only one small study supports it.

Topilutamide vial

DETAILED OVERVIEW

What is Topilutamide?

Topilutamide (also called fluridil) is a hormone-blocking product applied to the scalp for male and female pattern hair loss. Under the brand name Eucapil it is sold in the Czech Republic and a few other EU countries as a cosmetic or over-the-counter product; it is not approved as a medicine, it is not registered in the United States, and its availability differs from country to country.

In the hair follicle it pushes DHT (dihydrotestosterone, a strong male hormone) off its binding site, so it may slow the thinning of the hairs. It was designed to break down quickly into inactive products once it reaches the bloodstream, so in theory it acts only locally. In humans only a single small early study has been done: it was well tolerated, no hormone effect was seen in the body, and favorable signs of hair growth were described. There is no large confirmatory study, so the evidence is weaker than for minoxidil or finasteride. Mild redness, itching and dryness may occur. It should be avoided in pregnancy and breastfeeding because there is not enough data.

Other name / brand

Fluridil · Eucapil (Czech Republic/EU)

Status

Marketed cosmetic/OTC (EU); not an FDA-approved drug

Mechanism of action

Local androgen receptor blocker; quickly inactivated in the blood

Evidence

Limited: one small vehicle-controlled study (Sovak 2002)

Data console

Lab data

Classification-
StructureN/A
Molecular weightN/A
Target area-
Storage2–8°C
Stability~30 days reconstituted

Safety

Side effects, stop signs, contraindications

Side effects · 3

  • Local scalp reactions: mild redness, itching or dryness at the application site; in the (small) clinical study tolerability was good, with no systemic antiandrogen symptoms.
  • Limited evidence: efficacy and long-term safety rest on small, early clinical data and cosmetic-marketing experience; there is no large confirmatory phase 3 trial.
  • Designed for local action: the molecule deliberately hydrolyzes quickly to inactive metabolites, so systemic antiandrogen effect is minimal – but the full human safety picture rests on a small sample.

Contraindications · 3

  • Known hypersensitivity to topilutamide (fluridil) or the vehicle.
  • Broken, inflamed or infected scalp: withhold until it heals.
  • Pregnancy and breastfeeding: although systemic exposure is minimal by design, avoid or discuss with a physician due to limited data.

Related Hair & Skin

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Topilutamide?

Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.